Drug reference
fluocinolone acetonide
Glucocorticoid · Anti-inflammatory; Immunomodulator
GlucocorticoidAnti-inflammatory; Immunomodulator
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
diabetic macular edema (in patients who had no clinically significant rise in intraocular pressure when treated with corticosteroids)chronic noninfectious uveitis affecting the posterior segment of the eyeVariety of dermatological conditionsSevere inflammatory conditionsUnresponsive eczemaPsoriasis
Dosing
- Adult
- 0.025% ointment (potent); 0.01% ointment and skin lotion (moderately potent)
Side effects
Common
Thinning of epidermisDermal atrophyTelangiectasiaStriaeEasy bruisingHypopigmentationDelayed wound healingFungal and bacterial infections
Serious
- posterior subcapsular cataracts
- secondary infections
- secondary open-angle glaucoma
- Adrenal pituitary suppression (with large, repeated amounts)
- Cushing’s syndrome (rarely)
Related guidelines
Other Glucocorticoid drugs
Ask House about fluocinolone acetonide
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: KD Tripathi 7e, Goodman & Gilman 14e·Updated: 2026-05-10